- Home
- PBYI vs PCYO Comparison
PBYI vs PCYO Comparison
Compare PBYI & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | PCYO |
|---|---|---|
| Founded | 2010 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 267.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PBYI | PCYO |
|---|---|---|
| Price | $5.96 | $11.09 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 372.8K | 45.7K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.87 | 12.50 |
| EPS | ★ 0.74 | 0.54 |
| Revenue | ★ $211,995,000.00 | $26,087,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $8.01 | $20.44 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.58 | $9.65 |
| 52 Week High | $6.12 | $12.98 |
Technical Indicators
Market Signals| Indicator | PBYI | PCYO |
|---|---|---|
| Relative Strength Index (RSI) | 66.14 | 40.94 |
| Support Level | $5.51 | $11.39 |
| Resistance Level | $5.73 | $11.87 |
| Average True Range (ATR) | 0.22 | 0.37 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 95.76 | 2.62 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.